Home › Kanser sa Suso › Connecticut › Bridgeport
Pag-aaral pangklinika para sa Kanser sa Suso sa Bridgeport, CT
Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Bridgeport. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Nagre-recruitPhase 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 mi ang layo
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Nagre-recruitPhase 3
- Research Site, Stony Brook · 18 mi ang layo
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Nagre-recruitPhase 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 mi ang layo
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 mi ang layo
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Nagre-recruit
- Stony Brook Cancer Center, Stony Brook · 18 mi ang layo
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Nagre-recruitPhase 1/2
- Stony Brook University Hospital, Stony Brook · 18 mi ang layo
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Nagre-recruitPhase 3
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Nagre-recruitPhase 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi ang layo
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Nagre-recruitPhase 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 mi ang layo
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 mi ang layo
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 mi ang layo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Nagre-recruitPhase 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi ang layo
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi ang layo
- at 1 pa
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Nagre-recruitPhase 2
- Stony Brook Cancer Center, Stony Brook · 18 mi ang layo
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Nagre-recruitPhase 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 mi ang layo
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 mi ang layo
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Nagre-recruitPhase 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 mi ang layo
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Nagre-recruitPhase 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi ang layo
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Nagre-recruitPhase 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 mi ang layo
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Nagre-recruitPhase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi ang layo
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi ang layo
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Nagre-recruitObservasyonal na pag-aaral
- Stony Brook Medicine, Stony Brook · 18 mi ang layo
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Nagre-recruitMaagang Phase 1
- Stony Brook Breast Center, Stony Brook · 18 mi ang layo
Definitive Radiation Therapy for Inoperable Breast Cancer
Nagre-recruit
- Stony Brook University Cancer Center, Stony Brook · 18 mi ang layo
Definitive Radiation for High-Risk Spine Metastases
Nagre-recruitPhase 2
- Stony Brook University Hospital, Stony Brook · 18 mi ang layo
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Nagre-recruitObservasyonal na pag-aaral
- Stony Brook University Cancer Center, Stony Brook · 18 mi ang layo
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY136 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA112 pag-aaral
- Nashville, TN81 pag-aaral
- Los Angeles, CA73 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Queens, NY64 pag-aaral
- Durham, NC64 pag-aaral
- Chicago, IL59 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa Bridgeport
- Non-Small Cell Lung Cancer14 pag-aaral
- Kanser sa Baga13 pag-aaral
- Acute Myeloid Leukemia12 pag-aaral
- Sakit sa Puso at Ugat ng Dugo9 pag-aaral
- Kanser (lahat ng uri)8 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg8 pag-aaral
- Metastatic Cancer7 pag-aaral
- Pagkabigo ng Puso7 pag-aaral
- Brain Aneurysm6 pag-aaral
- Multiple Myeloma6 pag-aaral
- Kanser sa Prostate6 pag-aaral
- Kanser sa Ovary5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.